Multimodality imaging plays a pivotal role in evaluating inflammatory cardiomyopathy, particularly when cardiac sarcoidosis (CS) is suspected. Symptoms of CS include unexplained high-grade AV block, ventricular arrhythmias, reduced left ventricular function, or regional wall thinning without coronary disease. The best evaluation combines cardiac magnetic resonance imaging (MRI) for structural and scar assessment with fluorodeoxyglucose (FDG)-positron emission tomography (PET) for detecting active inflammation and extracardiac involvement.
In this interview, Michelle Kittleson MD, FACC and Ron Blankstein, MD, FACC discuss "Multimodality Imaging in Inflammatory Cardiomyopathy."
Subscribe on Apple Podcasts | Subscribe to ACCEL
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research